Tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane
C24H33FN4O3S — CID 167584254
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane
Tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane (PubChem CID 167584254) has the molecular formula C24H33FN4O3S and a molecular weight of 476.62 g/mol. Its IUPAC name is tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane.
Molecular Properties
| Compound Name | Tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane |
|---|---|
| PubChem CID | 167584254 |
| Molecular Formula | C24H33FN4O3S |
| Molecular Weight | 476.62 g/mol |
| Exact Mass | 476.23 |
| IUPAC Name | tert-butyl (3S)-3-[4-(7-fluoroquinolin-4-yl)piperazine-1-carbonyl]piperidine-1-carboxylate;sulfane |
| SMILES | CC(C)(C)OC(=O)N1CCC[C@H](C(=O)N2CCN(c3ccnc4cc(F)ccc34)CC2)C1.S |
| InChI | InChI=1S/C24H31FN4O3.H2S/c1-24(2,3)32-23(31)29-10-4-5-17(16-29)22(30)28-13-11-27(12-14-28)21-8-9-26-20-15-18(25)6-7-19(20)21;/h6-9,15,17H,4-5,10-14,16H2,1-3H3;1H2/t17-;/m0./s1 |
| InChIKey | HORPEDBUKHBJCZ-LMOVPXPDSA-N |
| XLogP | 3.78 |
| TPSA | 65.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 476.62 |
| LogP ≤ 5 | 3.78 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167584254 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.